AI brief of an SEC Form 8-K · Apimeds Pharmaceuticals US, Inc. (APUS)

Apimeds' MindWave signs two blockchain service deals; dollar value not disclosed

Neutral Impact 3 of 5 product/contract Written later

Apimeds Pharmaceuticals' subsidiary MindWave Innovations disclosed two 12-month technology agreements: one with AQUAE Holdings for the AQUAEChain platform (announced September 24, 2026) and one with Flash Sports & Media Holdings (FLZH) for the FlashChain network (announced September 29, 2026). Both agreements pay MindWave partly in tokens or shares, and the parties have not disclosed the aggregate dollar value, so the filing gives no figure for the effect on Apimeds' finances.

Key points

  • AQUAEChain agreement with AQUAE Holdings Pte. Ltd. was effective September 14, 2026; MindWave to receive a 20% allocation of ALCI Credits issued and outstanding, calculated quarterly.
  • FlashChain agreement with Flash Sports & Media Holdings, Inc. (FLZH) runs 12 months; MindWave to receive FLZH common shares and a 20% allocation of FLASH TOKEN total supply.
  • Parties have not publicly disclosed the aggregate dollar value of the consideration for the FlashChain agreement.
  • FlashChain agreement provides for an annual maintenance fee equal to 50% of the applicable contract consideration, as specified in the agreement.

The filing

CompanyApimeds Pharmaceuticals US, Inc. (APUS)
Form8-K, current report
Filed with the SECSep 29, 2026, 4:15 PM ET
Accession number0001213900-26-104668

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.